Author:
Albrecht Eva,Waldenberger Melanie,Krumsiek Jan,Evans Anne M.,Jeratsch Ulli,Breier Michaela,Adamski Jerzy,Koenig Wolfgang,Zeilinger Sonja,Fuchs Christiane,Klopp Norman,Theis Fabian J.,Wichmann H.-Erich,Suhre Karsten,Illig Thomas,Strauch Konstantin,Peters Annette,Gieger Christian,Kastenmüller Gabi,Doering Angela,Meisinger Christa
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference48 articles.
1. Ahn, S. Y., et al. (2011). Linkage of organic anion transporter-1 to metabolic pathways through integrated “omics”-driven network and functional analysis. Journal of Biological Chemistry, 286, 31522–31531.
2. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, 57, 289–300.
3. Benjamini, Y., & Yekutieli, D. (2001). The control of the false discovery rate in multiple testing under dependency. The Annals of Statistics, 29, 1165–1188.
4. Berry, C. E., & Hare, J. M. (2004). Xanthine oxidoreductase and cardiovascular disease: Molecular mechanisms and pathophysiological implications. Journal of Physiology, 555, 589–606.
5. Birkett, D. J., Miners, J. O., Valente, L., Lillywhite, K. J., & Day, R. O. (1997). 1-Methylxanthine derived from caffeine as a pharmacodynamic probe of oxypurinol effect. British Journal of Clinical Pharmacology, 43, 197–200.
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献